EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations

Marie Ouarné, Andreia Pena, Daniela Ramalho, Nadine V Conchinha, Tiago Costa, Romain Enjalbert, Ana M Figueiredo, Marta Pimentel Saraiva, Yulia Carvalho, Miguel O Bernabeu, Lenka Henao Misikova, S Paul Oh und 1 weitere

Cardiovascular Research · 04.12.2024 · 120 (15) · 1967-1984

DOI: 10.1093/cvr/cvae160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 23.09.2024. Verfasst von Marie Ouarné und 12 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal. Hauptthemen laut MEDLINE: Arteriovenous Malformations, Endothelial Cells, Signal Transduction, Cell Movement. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondation LeDucq, European Commission, La Caixa Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Arteriovenous malformations (AVMs), a disorder characterized by direct shunts between arteries and veins, are associated with genetic mutations. However, the mechanisms leading to AV shunt formation and how shunts can be reverted are poorly understood. Methods and results Here, we report that oxygen-induced retinopathy (OIR) protocol leads to the consistent and stereotypical formation of AV shunts in non-genetically altered mice. OIR-induced AV shunts show all the canonical markers of AVMs. Genetic and pharmacological interventions demonstrated that changes in the volume of venous endothelial cells (EC)—hypertrophic venous cells—are the initiating step promoting AV shunt formation, whilst EC proliferation or migration played minor roles. Inhibition of the mTOR pathway prevents pathological increases in EC volume and significantly reduces the formation of AV shunts. Importantly, we demonstrate that ALK1 signalling cell-autonomously regulates EC volume in pro-angiogenic conditions, establishing a link with hereditary haemorrhagic telangiectasia-related AVMs. Finally, we demonstrate that a combination of EC volume control and EC migration is associated with the regression of AV shunts.

Conclusion

Our findings highlight that an increase in the EC volume is the key mechanism driving the initial stages of AV shunt formation, leading to asymmetric capillary diameters. Based on our results, we propose a coherent and unifying timeline leading to the fast conversion of a capillary vessel into an AV shunt. Our data advocate for further investigation into the mechanisms regulating EC volume in health and disease as a way to identify therapeutic approaches to prevent and revert AVMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous MalformationsEndothelial CellsSignal TransductionCell MovementDisease Models, AnimalTOR Serine-Threonine KinasesAnimalsActivin Receptors, Type IMice, Inbred C57BLCell SizeRetinal ArteryCell ProliferationMTOR InhibitorsRetinal VesselsRetinal VeinPhenotypeOxygenRetinal NeovascularizationActivin Receptors, Type II

Stichwörter der Autor:innen

AngiogenesisArteriovenous malformationsCell volumeOxygen-induced retinopathy

Substanzen

TOR Serine-Threonine KinasesmTOR protein, mouseAcvrl1 protein, mouseActivin Receptors, Type IMTOR InhibitorsOxygenActivin Receptors, Type II

Autor:innen und Institutionen

  • Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon 1649-028, Portugal.
  • Católica Biomedical Research Centre, Universidade Católica Portuguesa, Católica Medical School, Lisbon 1649-023, Portugal.
  • Centre for Medical Informatics, Usher Institute, The University of Edinburgh, Edinburgh EH16 4UX, UK.
  • The Bayes Centre, The University of Edinburgh, Edinburgh EH8 9BT, UK.
  • Barrow Aneurysm & AVM Research Center, Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013, USA.

ORCID-Profile: Cláudio A Franco

Förderung

  • Fondation LeDucq
  • European Commission
  • La Caixa Foundation
  • EU MSCA
  • European Research Council
  • 'la Caixa' Foundation

Zitieren

APA

Ouarné, M., Pena, A., Ramalho, D., Conchinha, N. V., Costa, T., Enjalbert, R., Figueiredo, A. M., Saraiva, M. P., Carvalho, Y., Bernabeu, M. O., Henao Misikova, L., Oh, S. P., & Franco, C. A. (2024). A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations. Cardiovascular Research, 120(15), 1967-1984. https://doi.org/10.1093/cvr/cvae160

Vancouver

Ouarné M, Pena A, Ramalho D, Conchinha NV, Costa T, Enjalbert R, et al. A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations. Cardiovascular Research. 2024;120(15):1967-1984. doi:10.1093/cvr/cvae160

BibTeX
@article{Ouarn2024,
  author = {Ouarné, Marie and Pena, Andreia and Ramalho, Daniela and Conchinha, Nadine V and Costa, Tiago and Enjalbert, Romain and Figueiredo, Ana M and Saraiva, Marta Pimentel and Carvalho, Yulia and Bernabeu, Miguel O and Henao Misikova, Lenka and Oh, S Paul and Franco, Cláudio A},
  title = {A non-genetic model of vascular shunts informs on the cellular mechanisms of formation and resolution of arteriovenous malformations},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {15},
  pages = {1967--1984},
  doi = {10.1093/cvr/cvae160}
}
Kostenlos starten →